Making Automation the Standard: An Annex 1 Overview

This article serves as a technical report detailing the final version of the European Union (EU) good manufacturing practice (GMP) Annex 1, which took effect in August 2023. The report outlines the emphasis on automated quality control (QC) technologies aimed at reducing risks associated with microbial, particulate, and pyrogen contamination in sterile pharmaceuticals. It highlights the compliance challenges that developers and manufacturers will face, not only within Europe but also in the United States as FDA guidelines evolve. The article discusses the necessity for manufacturers to adopt validated platforms that enhance compliance while minimizing risk, particularly through the use of automated systems. It also notes that the Annex introduces a need for more rigorous risk assessments to justify processes and reduce human intervention, which is a significant source of contamination. The report concludes by indicating that the broader scope of Annex 1 will necessitate substantial changes across global supply chains, impacting various sterile product types and manufacturing processes.